Evidence map›Paper›PMID 41064697›Full record

ArticleOpen forum infectious diseases2025

Accelerating Cough-Based Algorithms for Pulmonary Tuberculosis Screening: Results From the CODA TB DREAM Challenge.

Devan Jaganath, Solveig K Sieberts, Mihaja Raberahona, Sophie Huddart, Larsson Omberg, Rivo Rakotoarivelo, Issa Lyimo, Omar Lweno, Devasahayam J Christopher, Nguyen Viet Nhung and 23 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Devan JaganathDivision of Pediatric Infectious Diseases, University of California, San Francisco, California, San Francisco, USA.ORCID https://orcid.org/0000-0002-8555-5667
Solveig K SiebertsSage Bionetworks, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-1033-0954
Mihaja RaberahonaCHU Joseph Rasera Befelatanana, Antananarivo, Madagascar.ORCID https://orcid.org/0000-0001-8857-5834
Sophie HuddartCenter for Tuberculosis, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0001-6425-3371
Larsson OmbergSage Bionetworks, Seattle, Washington, USA.
Rivo RakotoariveloCHU Tambohobe Fianarantsoa, Haute-Matsiatra, Madagascar.
Issa LyimoEnvironmental and Ecological Sciences & Interventions and Clinical Trials Departments, Ifakara Health Institute, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0001-5804-7352
Omar LwenoEnvironmental and Ecological Sciences & Interventions and Clinical Trials Departments, Ifakara Health Institute, Dar es Salaam, Tanzania.
Devasahayam J ChristopherDepartment of Pulmonary Medicine, Christian Medical College, Vellore (Ranipet Campus), Tamil Nadu, India.ORCID https://orcid.org/0000-0002-9405-8494
Nguyen Viet NhungNational Tuberculosis Programme, Hanoi, Vietnam.ORCID https://orcid.org/0000-0002-5447-133X
William WorodriaWalimu, Kampala, Uganda.ORCID https://orcid.org/0000-0002-8531-5567
Charles YuDe La Salle Medical and Health Sciences Institute, Dasmarinas Cavite, Philippines.
Jhih-Yu ChenGraduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0003-1652-8566
Sz-Hau ChenIndustrial Information Department, Development Center for Biotechnology, Taipei, Taiwan.ORCID https://orcid.org/0009-0005-3476-0440
Tsai-Min ChenGraduate Program of Data Science, National Taiwan University and Academia Sinica, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-1143-0677
Chih-Han HuangDepartment of Data Science, ANIWARE, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-7339-1194
Kuei-Lin HuangSchool of Medicine, China Medical University, Taichung, Taiwan.
Filip MulierFlywheel.io, Minneapolis, Minnesota, USA.
Daniel RafterFlywheel.io, Minneapolis, Minnesota, USA.
Edward S C ShihInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-8175-0393
Yu TsaoGraduate Program of Data Science, National Taiwan University and Academia Sinica, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-6956-0418
Hsuan-Kai WangIndependent Researcher, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-2157-0091
Chih-Hsun WuArtificial Intelligence and E-Learning Center, National Chengchi University, Taipei, Taiwan.
Christine BachmanGlobal Health Labs, Bellevue, Washington, USA.
Stephen BurkotGlobal Health Labs, Bellevue, Washington, USA.
Puneet DewanGlobal Health Labs, Bellevue, Washington, USA.
Sourabh KulhareGlobal Health Labs, Bellevue, Washington, USA.
Peter M SmallDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Vijay YadavSage Bionetworks, Seattle, Washington, USA.
Simon Grandjean LapierreCentre de Recherche du Centre Hospitalier de L'Université de Montréal, Immunopathology Axis, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0003-3646-1573
Grant TheronDSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-9216-2415
Adithya CattamanchiCenter for Tuberculosis, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0002-6553-2601
Cough Diagnostic Algorithm for Tuberculosis (CODA TB) DREAM Challenge Consortium

Funding

The Center for Innovation in Point-of-Care Technologies for HIV/AIDS atNorthwestern University (C-THAN) Supplemental RequestU54EB027049 · NIBIB · NORTHWESTERN UNIVERSITY · PI Chad J Achenbach, SALLY Maureen MCFALL · 2018 to 2026
$24.0M
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)U01AI152087 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CATTAMANCHI, ADITHYA, DENKINGER, CLAUDIA MARIA · 2020 to 2024
$19.3M
HIV and Mycobacterial Disease in MaliD43TW010350 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI MAIGA, ALMOUSTAPHA ISSIAKA, MURPHY, ROBERT LEO · 2016 to 2025
$3.0M
Host Proteomic Biosignatures for a Urine-based Diagnosis of Pulmonary Tuberculosis in ChildrenK23HL153581 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAGANATH, DEVAN · 2020 to 2024
$946k
Pre- and post-treatment lung microbiota, metabolome and immune signatures at the site of disease in patients with active pulmonary tuberculosisR01AI136894 · NIAID · STELLENBOSCH UNIVERSITY · PI THERON, GRANT DE VOS · 2019 to 2023
$678k
FIC NIH HHS D43 TW010350NHLBI NIH HHS K23 HL153581NIAID NIH HHS R01 AI136894NIAID NIH HHS U01 AI152087NIBIB NIH HHS U54 EB027049
6 · The paper itself

Abstract

Background: Open-access data challenges can accelerate innovation in artificial intelligence-based tools. In the Cough Diagnostic Algorithm for Tuberculosis (CODA TB) DREAM Challenge, we developed and independently validated cough sound-based artificial intelligence algorithms for tuberculosis screening. Methods: We included data from 2143 adults with ≥2 weeks of cough from outpatient clinics in India, Madagascar, the Philippines, South Africa, Tanzania, Uganda, and Vietnam. A standard tuberculosis evaluation was completed, and ≥3 solicited coughs were recorded using a smartphone. We invited teams to develop models using training data to classify microbiologically confirmed tuberculosis disease using (1) cough sound features only and/or (2) cough sound features with routinely available clinical data. After 4 months, they submitted the algorithms for independent test set validation. Models were ranked by area under the receiver operating characteristic curve (AUROC) and partial AUROC (pAUROC) to achieve at least 80% sensitivity and 60% specificity. Results: Eleven cough models and 6 cough-plus-clinical models were submitted. AUROCs for cough models ranged from 0.69 to 0.74, and the highest performing model achieved 55.5% specificity (95% confidence interval, 47.7%-64.2%) at 80% sensitivity. The addition of clinical data improved AUROCs (range, 0.78-0.83); 5 of the 6 models reached the target pAUROC, and the highest performing model had 73.8% specificity (95% confidence interval, 60.8%-80.0%) at 80% sensitivity. The AUROC varied by country and was higher among male and human immunodeficiency virus-negative individuals. Conclusions: In a short period, an open-access data challenge facilitated the development of new cough-based tuberculosis algorithms and demonstrated potential as a tuberculosis screening tool.

Indexed as

artificial intelligencecoughdata challengediagnosticstuberculosis

Identifiers

PMID41064697
PMCPMC12502651

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.